Hai-liang X. Li
NO. 127, Dongming Road
Zhengzhou, 450003, China
Zhengzhou, 450003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02).
Journal: Frontiers in oncology
Published: April 22, 2025
BI-RADS application for breast cancer screening in primary healthcare settings: assessing protocol adherence and diagnostic validity.
Journal: Frontiers in oncology
Published: March 25, 2025
An Ex Vivo Animal Organ Model Tailored for Fluoroscopically Guided Percutaneous Jejunostomy.
Journal: Cardiovascular and interventional radiology
Published: February 01, 2025
Transarterial chemoembolization plus apatinib for unresectable hepatocellular carcinoma: a multicenter, randomized, open-label, phase III trial.
Journal: BMC medicine
Published: June 06, 2024
TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts.
Journal: Journal of hepatocellular carcinoma
Published: May 27, 2024
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213).
Journal: Journal of cachexia, sarcopenia and muscle
Published: March 14, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
Journal: EClinicalMedicine
Published: January 10, 2024
The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity.
Journal: Frontiers in immunology
Published: October 12, 2023
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.
Journal: Hepatology international
Published: July 07, 2023
Mammary myofibroblastoma: a clinicopathological analysis of fifteen cases
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: July 06, 2023
Last Updated: 09/26/2026